Registered entities
Aclaris Therapeutics, Inc.
Reg. No. 1557746United States
Aclaris Therapeutics Inc
Reg. No. 460571712United States
Aclaris Therapeutics Inc.
Reg. No. 46-0571712United States
Innovation
32 patent families (16 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,994 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 10 |
| 2024 | 6 |
| 2025 | 13 |
| 2026 | 2 |
Social engagement
Social engagement: 9.1K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
15 investors on record; lead investors include Rock Springs Capital, RA Capital Management, Aperture Venture Partners, F-Prime Capital; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 53% |
| Private equity | 3 | 20% |
| Other / undisclosed | 4 | 27% |
Recent activity
4 Jun 2026
Event
Jefferies Global Healthcare Conference
28 May 2026
Event
Jefferies Global Healthcare Conference
8 May 2026
Event
Bank of America Healthcare Conference